We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 10,000 results
  1. Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcoma

    Background

    Dedifferentiated chondrosarcoma (DDCS) is an aggressive bone tumour with a poor prognosis and no effective treatment. Because changes in...

    Eijiro Shimada, Yoshihiro Matsumoto, ... Yasuharu Nakashima in British Journal of Cancer
    Article 11 January 2022
  2. MYC protein interactors in gene transcription and cancer

    The transcription factor and oncoprotein MYC is a potent driver of many human cancers and can regulate numerous biological activities that contribute...

    Corey Lourenco, Diana Resetca, ... Linda Z. Penn in Nature Reviews Cancer
    Article 29 June 2021
  3. Transcriptomic landscape based on annotated clinical features reveals PLPP2 involvement in lipid raft-mediated proliferation signature of early-stage lung adenocarcinoma

    Background

    Image-based screening improves the detection of early-stage lung adenocarcinoma (LUAD)but also highlights the issue of high false-positive...

    Yibei Wang, Ziwei Miao, ... Bo Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 23 November 2023
  4. The intratumour microbiota and neutrophilic inflammation in squamous cell vulvar carcinoma microenvironment

    Background

    A causal link between microbiota composition (dysbiosis) and oncogenesis has been demonstrated for several types of cancer. Neutrophils...

    Natalia Rustetska, Magdalena Szczepaniak, ... Magdalena Kowalewska in Journal of Translational Medicine
    Article Open access 28 April 2023
  5. Telocytes in the Tumor Microenvironment

    There are several theories explaining the communication between cells in the context of tumor development. Over the years, interactions between...
    Veronika Aleksandrovych, Krzysztof Gil in Tumor Microenvironment
    Chapter 2021
  6. Plant-derived exosome-like nanoparticles for microRNA delivery in cancer treatment

    Plant-derived exosome-like nanoparticles (PELNs) are natural nanocarriers and effective delivery systems for plant microRNAs (miRNAs). These...

    Chun Yi, Linzhu Lu, ... Xuefei Tian in Drug Delivery and Translational Research
    Article 17 May 2024
  7. Evidence for a causal role by human papillomaviruses in prostate cancer – a systematic review

    It is hypothesised that high risk for cancer human papillomaviruses (HPVs) have a causal role in prostate cancer.

    In 26 case control studies, high...

    James S. Lawson, Wendy K. Glenn in Infectious Agents and Cancer
    Article Open access 14 July 2020
  8. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

    Colorectal cancer (CRC) is a leading cause of mortality worldwide. We conducted a genome-wide association study meta-analysis of 100,204 CRC cases...

    Ceres Fernandez-Rozadilla, Maria Timofeeva, ... Ulrike Peters in Nature Genetics
    Article 20 December 2022
  9. Extrachromosomal DNA amplifications in cancer

    Extrachromosomal DNA (ecDNA) amplification is an important driver alteration in cancer. It has been observed in most cancer types and is associated...

    Eunhee Yi, Rocío Chamorro González, ... Roel G. W. Verhaak in Nature Reviews Genetics
    Article 11 August 2022
  10. Translational Reprogramming of mRNA in Oxidative Stress and Cancer

    Oxidative distress is a hallmark of cancer. Neoplastic cells produce elevated levels of reactive oxygen species that trigger signaling pathways and...
    Reference work entry 2022
  11. Analysis of the Frequency of 10 Polymorphic Markers of CDKN2A and RB1 Genes in Russian Populations

    The study of population frequencies of rare clinically significant alleles is a prerequisite of the development of personalized medicine. We...

    M. V. Olkova, O. P. Balanovsky in Bulletin of Experimental Biology and Medicine
    Article 10 January 2022
  12. A truncated and catalytically inactive isoform of KDM5B histone demethylase accumulates in breast cancer cells and regulates H3K4 tri-methylation and gene expression

    KDM5B histone demethylase is overexpressed in many cancers and plays an ambivalent role in oncogenesis, depending on the specific context. This...

    Elena Di Nisio, Valerio Licursi, ... Rodolfo Negri in Cancer Gene Therapy
    Article Open access 26 January 2023
  13. Pemigatinib in previously treated solid tumors with activating FGFR1–FGFR3 alterations: phase 2 FIGHT-207 basket trial

    Fibroblast growth factor receptor ( FGFR ) alterations drive oncogenesis in multiple tumor types. Here we studied pemigatinib, a selective, potent,...

    Jordi Rodón, Silvia Damian, ... Lipika Goyal in Nature Medicine
    Article Open access 06 May 2024
  14. Translational Reprogramming of mRNA in Oxidative Stress and Cancer

    Oxidative distress is a hallmark of cancer. Neoplastic cells produce elevated levels of reactive oxygen species that trigger signaling...
    Living reference work entry 2022
  15. Clinical and Immunological Significance of ANKRD52 in Pan-Cancer

    Ankyrin repeat domain 52 (ANKRD52) is a regulatory component of the protein phosphatase 6 (PP6) holoenzyme. Evidence has emerged to suggest...

    Hui-Zi Yin, Meng-Chun Zhang, Hao Wu in Biochemical Genetics
    Article 31 January 2024
  16. Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden

    Background

    Epidemiological evidence suggests that synchronous or metachronous presentation of breast and thyroid cancers exceeds that predicted by...

    Bence Bakos, András Kiss, ... Péter Lakatos in BMC Cancer
    Article Open access 15 June 2021
  17. circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3

    Background

    Docetaxel (DTX) is the most widely prescribed first-line chemotherapy for advanced prostate cancer (PCa). Unfortunately, DTX resistance...

    Haoli Yin, Haixiang Qin, ... Hongqian Guo in Biomarker Research
    Article Open access 13 July 2022
  18. Epi-Drugs Targeting RNA Dynamics in Cancer

    From the early discovery of ribonucleic acid in 1868, the RNA world has seen constant evolution. To date, more than ten types of RNA species are...
    Guglielmo Bove, Ida Lettiero, ... Carmela Dell’Aversana in Cancer Research: An Interdisciplinary Approach
    Chapter 2023
  19. Recent advances in the developmental origin of neuroblastoma: an overview

    Neuroblastoma (NB) is a pediatric tumor that originates from neural crest-derived cells undergoing a defective differentiation due to genomic and...

    Mirco Ponzoni, Tiziana Bachetti, ... Patrizia Perri in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 March 2022
  20. Aging and cancer

    Aging and cancer exhibit apparent links that we will examine in this review. The null hypothesis that aging and cancer coincide because both are...

    Léa Montégut, Carlos López-Otín, Guido Kroemer in Molecular Cancer
    Article Open access 18 May 2024
Did you find what you were looking for? Share feedback.